Related Experiment Video
Updated: May 21, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
Non-IgE mediated food allergy - update of recent progress in mucosal immunity
1Division of Allergy/ Immunology and Infectious Diseases, Department of Pediatrics, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, F570A, MSB, 185 South Orange Ave., Newark, NJ 07101-1709, USA. jyanouha@umdnj.edu
Abstract:
As opposed to IgE mediated food allergy (IFA) which can cause fatal outcomes, non-IgE mediated FA (NFA) was initially thought to be a benign condition mediated by cellular immune responses, primarily affecting the GI mucosa. NFA children were thought to recover well upon avoidance of offending food. Although pathogenesis of NFA is still not well understood, recent studies indicate widely variable clinical manifestations of NFA. In parallel to our better appreciation of clinical features of NFA, complex regulatory mechanisms of gut immune homeostasis have become known with progress in our understanding of the gut mucosal immune system. In addition, a role of gut commensal flora on the gut immune system has also become better understood along with the effects of dietary components. Subtle changes in interactions between environmental factors (microbiota, dietary components, etc.) and the gut immune responses can affect gut immune homeostasis, which can result in undesired adverse reactions to food proteins (FPs). This review discusses recent progress in our understanding of the regulatory mechanisms of gut immune homeostasis and recently revealed widely variable clinical presentations of NFA with respect to it pathogenesis.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Gastritis II: Pathophysiology
Allergic Reactions: Anaphylaxis
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

